×
Entrez Id: 4824
Gene Symbol: NKX3-1
NKX3-1
Prostatic Neoplasms
0.600
Biomarker
CTD_human
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer.
22610119 2012
×
Entrez Id: 5728
Gene Symbol: PTEN
PTEN
Prostatic Neoplasms
0.600
Biomarker
CTD_human
Resveratrol and prostate cancer: promising role for microRNAs.
21714127 2011
×
Entrez Id: 5728
Gene Symbol: PTEN
PTEN
Prostatic Neoplasms
0.600
Biomarker
CTD_human
Regulation of phosphatase homologue of tensin protein expression by bone morphogenetic proteins in prostate epithelial cells.
21456062 2011
×
Entrez Id: 5728
Gene Symbol: PTEN
PTEN
Prostatic Neoplasms
0.600
Biomarker
CTD_human
Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines.
20729295 2010
×
Entrez Id: 367
Gene Symbol: AR
AR
Prostatic Neoplasms
0.600
Biomarker
CTD_human
Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines.
20729295 2010
×
Entrez Id: 367
Gene Symbol: AR
AR
Prostatic Neoplasms
0.600
Therapeutic
CTD_human
Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines.
20729295 2010
×
Entrez Id: 3479
Gene Symbol: IGF1
IGF1
Prostatic Neoplasms
0.600
Biomarker
CTD_human
Microarray comparison of prostate tumor gene expression in African-American and Caucasian American males: a pilot project study.
19208208 2009
×
Entrez Id: 5728
Gene Symbol: PTEN
PTEN
Prostatic Neoplasms
0.600
Biomarker
CTD_human
Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate.
19396168 2009
×
Entrez Id: 367
Gene Symbol: AR
AR
Prostatic Neoplasms
0.600
Therapeutic
CTD_human
Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor.
19011039 2009
×
Entrez Id: 367
Gene Symbol: AR
AR
Prostatic Neoplasms
0.600
Biomarker
CTD_human
Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor.
19011039 2009
×
Entrez Id: 5728
Gene Symbol: PTEN
PTEN
Prostatic Neoplasms
0.600
Biomarker
CTD_human
The pace of prostatic intraepithelial neoplasia development is determined by the timing of Pten tumor suppressor gene excision.
19081794 2008
×
Entrez Id: 367
Gene Symbol: AR
AR
Prostatic Neoplasms
0.600
Therapeutic
CTD_human
Effects of manganese superoxide dismutase silencing on androgen receptor function and gene regulation: implications for castration-resistant prostate cancer.
18829485 2008
×
Entrez Id: 367
Gene Symbol: AR
AR
Prostatic Neoplasms
0.600
Biomarker
CTD_human
Effects of manganese superoxide dismutase silencing on androgen receptor function and gene regulation: implications for castration-resistant prostate cancer.
18829485 2008
×
Entrez Id: 5728
Gene Symbol: PTEN
PTEN
Prostatic Neoplasms
0.600
Biomarker
CTD_human
Integrative molecular concept modeling of prostate cancer progression.
17173048 2007
×
Entrez Id: 367
Gene Symbol: AR
AR
Prostatic Neoplasms
0.600
Biomarker
CTD_human
Cellular changes in prostate cancer cells induced by intermittent androgen suppression.
17141945 2007
×
Entrez Id: 1499
Gene Symbol: CTNNB1
CTNNB1
Prostatic Neoplasms
0.600
Biomarker
CTD_human
Prostate tumors induced by the deletion of Apc have elevated levels of beta-catenin protein and are highly proliferative.17363566 2007
×
Entrez Id: 4824
Gene Symbol: NKX3-1
NKX3-1
Prostatic Neoplasms
0.600
Biomarker
CTD_human
Integrative molecular concept modeling of prostate cancer progression.
17173048 2007
×
Entrez Id: 367
Gene Symbol: AR
AR
Prostatic Neoplasms
0.600
Therapeutic
CTD_human
Androgen induces expression of the multidrug resistance protein gene MRP4 in prostate cancer cells.
17003774 2007
×
Entrez Id: 367
Gene Symbol: AR
AR
Prostatic Neoplasms
0.600
Biomarker
CTD_human
Androgen induces expression of the multidrug resistance protein gene MRP4 in prostate cancer cells.
17003774 2007
×
Entrez Id: 367
Gene Symbol: AR
AR
Prostatic Neoplasms
0.600
Therapeutic
CTD_human
Cellular changes in prostate cancer cells induced by intermittent androgen suppression.
17141945 2007
×
Entrez Id: 5728
Gene Symbol: PTEN
PTEN
Prostatic Neoplasms
0.600
Biomarker
CTD_human
PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer.
16421604 2006
×
Entrez Id: 367
Gene Symbol: AR
AR
Prostatic Neoplasms
0.600
Biomarker
CTD_human
Androgen receptor remains critical for cell-cycle progression in androgen-independent CWR22 prostate cancer cells.
16877366 2006
×
Entrez Id: 367
Gene Symbol: AR
AR
Prostatic Neoplasms
0.600
Therapeutic
CTD_human
Synthesis and biological evaluation of a nonsteroidal bromine-76-labeled androgen receptor ligand 3-[76Br]bromo-hydroxyflutamide.
16934689 2006
×
Entrez Id: 367
Gene Symbol: AR
AR
Prostatic Neoplasms
0.600
Therapeutic
CTD_human
Systematic replication study of reported genetic associations in prostate cancer: Strong support for genetic variation in the androgen pathway.
16998812 2006
×
Entrez Id: 3479
Gene Symbol: IGF1
IGF1
Prostatic Neoplasms
0.600
Biomarker
CTD_human
Insulin-like growth factor-I promotes migration in human androgen-independent prostate cancer cells via the alphavbeta3 integrin and PI3-K/Akt signaling.
16465378 2006